Key result
Digoxin is a widely prescribed digitalis drug whose clinical use and therapeutic monitoring are influenced by endogenous digitalis-like factors that can interfere with immunoassays.
Design
Review
Authors
Loading...
May warrant cautious digoxin level interpretation due to endogenous interference; leaves open refined assay validation in research.
This review highlights the complexities of therapeutic drug monitoring for digoxin, particularly the interference of endogenous digitalis-like factors in immunoassays.
Jortani et al. (1997) reported a review. Digoxin was evaluated. Digoxin is a widely prescribed digitalis drug whose clinical use and therapeutic monitoring are influenced by endogenous digitalis-like factors that can interfere with immunoassays.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: